P. Pergolini

发表

PlA1/PlA2 polymorphism does not influence response to Gp IIb-IIIa inhibitors in patients undergoing coronary angioplasty

H. Suryapranata, G. De Luca, P. Marino, 2013, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Gender Differences in Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy

H. Suryapranata, P. Marino, G. Bellomo, 2016, Cardiovascular Drugs and Therapy.

Diabetes mellitus, glucose control parameters and platelet reactivity in ticagrelor treated patients.

H. Suryapranata, G. De Luca, G. Bellomo, 2016, Thrombosis research.

Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2015, Expert opinion on pharmacotherapy.

Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy.

H. Suryapranata, G. De Luca, P. Marino, 2015, Atherosclerosis.

Impact of adenosine A2a receptor polymorphism rs5751876 on platelet reactivity in ticagrelor treated patients

H. Suryapranata, G. De Luca, P. Marino, 2018, Pharmacological research.

Impact of diabetes on immature platelets fraction and its relationship with platelet reactivity in patients receiving dual antiplatelet therapy

H. Suryapranata, G. De Luca, P. Marino, 2016, Journal of Thrombosis and Thrombolysis.

Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease.

H. Suryapranata, G. De Luca, P. Marino, 2017, Thrombosis research.

Prevalence and predictors of high-on treatment platelet reactivity during prasugrel treatment in patients with acute coronary syndrome undergoing stent implantation.

H. Suryapranata, G. De Luca, P. Marino, 2019, Journal of cardiology.

Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor.

H. Suryapranata, G. De Luca, P. Marino, 2016, Vascular pharmacology.

Reduced activity of B lymphocytes, recognised by Sysmex XN‐2000™ haematology analyser, predicts mortality in patients with coronavirus disease 2019

U. Dianzani, M. Pirisi, C. Rigamonti, 2020, International journal of laboratory hematology.

Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease.

H. Suryapranata, G. De Luca, P. Marino, 2016, Thrombosis research.

Vitamin D Binding Protein rs7041 polymorphism and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.

G. De Luca, P. Marino, G. Bellomo, 2017, Vascular pharmacology.

Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2015, Journal of cardiovascular pharmacology.

Below normal pre-procedural cardiac troponin I levels are associated with an adverse prognosis after percutaneous coronary interventions.

A. Jaffe, G. Bellomo, A. Rognoni, 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Impact of the rs73598374 polymorphism of the adenosine deaminase gene on platelet reactivity and long-term outcomes among patients with acute coronary syndrome treated with ticagrelor.

G. De Luca, M. Verdoia, R. Rolla, 2020, Thrombosis research.

Advanced age and high‐residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2016, Journal of thrombosis and haemostasis : JTH.

Impact of immature platelet fraction on platelet reactivity during prasugrel maintenance treatment

H. Suryapranata, G. De Luca, M. Verdoia, 2018, Platelets.

Impact of Long-Term Dual Antiplatelet Therapy on Immature Platelet Count and Platelet Reactivity

H. Suryapranata, G. De Luca, P. Marino, 2018, Angiology.

Parathyroid hormone levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with acetylsalicylic acid and clopidogrel or ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2016 .

Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2016, Platelets.

Prevalence and predictors of high-on treatment platelet reactivity with ticagrelor in ACS patients undergoing stent implantation.

H. Suryapranata, G. De Luca, P. Marino, 2016, Vascular pharmacology.

Immature platelet fraction and high-on treatment platelet reactivity with ticagrelor in patients with acute coronary syndromes

H. Suryapranata, G. De Luca, P. Marino, 2016, Journal of Thrombosis and Thrombolysis.

Impact of aging on platelet reactivity in diabetic patients receiving dual antiplatelet therapy

H. Suryapranata, G. De Luca, M. Verdoia, 2019, Journal of Thrombosis and Thrombolysis.

Impact of pre-procedural dual antiplatelet therapy on periprocedural myocardial infarction in patients undergoing percutaneous coronary interventions with adjunctive tirofiban.

H. Suryapranata, G. De Luca, L. Barbieri, 2018, Thrombosis research.

Impact of diabetes mellitus on immature platelet fraction and its association with coronary artery disease

H. Suryapranata, G. De Luca, M. Verdoia, 2020, Diabetes/metabolism research and reviews.

Low hemoglobin predicts high‐platelet reactivity and major cardiovascular ischemic events at long‐term follow‐up among ACS patients receiving dual antiplatelet therapy with ticagrelor

H. Suryapranata, G. De Luca, M. Verdoia, 2021, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

Ticagrelor and prasugrel in acute coronary syndrome: a single-arm crossover platelet reactivity study

H. Suryapranata, G. De Luca, M. Verdoia, 2021, Journal of cardiovascular medicine.

Gender differences in platelet reactivity in diabetic patients receiving dual antiplatelet therapy.

H. Suryapranata, G. De Luca, M. Verdoia, 2020, Cardiovascular revascularization medicine : including molecular interventions.

Vitamin D levels and platelet reactivity in diabetic patients receiving dual antiplatelet therapy.

H. Suryapranata, G. De Luca, M. Verdoia, 2019, Vascular pharmacology.

Platelet Larger Cell Ratio and High-on Treatment Platelet Reactivity During Dual Antiplatelet Therapy

H. Suryapranata, G. De Luca, P. Marino, 2015, Cardiovascular Drugs and Therapy.

Mean platelet volume and the extent of coronary artery disease: results from a large prospective study.

G. De Luca, P. Marino, G. Bellomo, 2009, Atherosclerosis.

Role of the laboratory in monitoring patients receiving dual antiplatelet therapy

M. Vidali, R. Rolla, R. Serino, 2012, International journal of laboratory hematology.

Antibodies against oxidized phospholipids in laboratory tests exploring lupus anti‐coagulant activity

G. Bellomo, M. Vidali, R. Rolla, 2007, Clinical and experimental immunology.

Heterozygous β-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C

G. Bellomo, C. Rigamonti, R. Rolla, 2006, Gut.

Low‐molecular‐weight‐heparin and pregnancy, when the dose does it: a nephrologist’s opinion: a rebuttal

C. Magnani, G. Bellomo, P. Stratta, 2011, Journal of thrombosis and haemostasis : JTH.

Cardiovascular Risk Profile of Patients Hospitalized for Myocardial Infarction is Undestimated by Traditional Risk Factors and is Better Estimated by a Genetic Analysis Based Upon Single Nucleotide Polymorphisms: A Retrospective Study

R. Rolla, A. Lupi, L. Rossi, 2018 .

Routine coagulation tests are not useful as a screening tool for the FII G20210A polymorphism.

G. Bellomo, M. Vidali, R. Rolla, 2014, Clinical laboratory.

Use of Metformin and Platelet Reactivity in Diabetic Patients Treated with Dual Antiplatelet Therapy.

H. Suryapranata, G. De Luca, M. Verdoia, 2018, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.

H. Suryapranata, G. De Luca, P. Marino, 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor.

H. Suryapranata, G. De Luca, P. Marino, 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Homocysteine Levels Influence Platelet Reactivity in Coronary Artery Disease Patients Treated With Acetylsalicylic Acid

H. Suryapranata, G. De Luca, P. Marino, 2015, Journal of cardiovascular pharmacology.

Reliability of Lupus Anticoagulant and Anti-phosphatidylserine/prothrombin Autoantibodies in Antiphospholipid Syndrome: A Multicenter Study

S. Baldovino, D. Roccatello, S. Sciascia, 2019, Front. Immunol..

Homocysteine levels and platelet reactivity in coronary artery disease patients treated with ticagrelor.

G. De Luca, M. Verdoia, M. Marcolongo, 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Multicenter evaluation of five assays for myoglobin determination.

M. Panteghini, F. Pagani, M. Plebani, 2000, Clinical chemistry.

Impact of aging on platelet reactivity in diabetic patients receiving dual antiplatelet therapy

H. Suryapranata, G. De Luca, M. Verdoia, 2019, Journal of Thrombosis and Thrombolysis.

Vitamin D levels and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2016, Platelets.

Body Mass Index and Platelet Reactivity During Dual Antiplatelet Therapy With Clopidogrel or Ticagrelor

H. Suryapranata, G. De Luca, P. Marino, 2015, Journal of Cardiovascular Pharmacology.

Acute lymphoblastic leukaemia in a child with hereditary elliptocytosis

H. Russcher, C. Rehder, A. Dorgalaleh, 2022 .

Parathyroid Hormone Levels and High-Residual Platelet Reactivity in Patients Receiving Dual Antiplatelet Therapy With Acetylsalicylic Acid and Clopidogrel or Ticagrelor.

H. Suryapranata, G. De Luca, P. Marino, 2016, Cardiovascular therapeutics.

Impact of atorvastatin or rosuvastatin co-administration on platelet reactivity in patients treated with dual antiplatelet therapy.

H. Suryapranata, G. De Luca, P. Marino, 2015, Atherosclerosis.